Reassuring Findings About Infants Exposed To Zidovudine

January 12, 1999

Children exposed to zidovudine (ZDV, AZT) in utero and as newborns and who escaped acquiring HIV from their infected mothers show no cancers or other adverse health effects up through preschool age, according to a new study from the National Institutes of Health (NIH). It is the first report to assess the late effects of AZT exposure in healthy HIV-uninfected children born to mothers who took the drug to prevent transmitting HIV to their offspring.

The study, sponsored by the Pediatric AIDS Clinical Trials Group (PACTG) and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), appears in the Jan. 13 issue of the Journal of the American Medical Association.

"These data are critically important because the current recommendation is to treat HIV-infected pregnant women with regimens that include AZT to prevent perinatal HIV transmission," says NIAID Director Anthony S. Fauci, M.D. "Although these findings are reassuring," he adds, "we need to continue to monitor these children for long-term adverse effects of the drug." The investigators plan to follow these children until at least age 21.

The 234 HIV-uninfected children evaluated in this report are part of PACTG 219, a long-term follow-up study that includes more than 2,200 children who have been enrolled in PACTG prevention and treatment protocols. The 234 children were born to mothers who participated in PACTG 076. This landmark NIH study showed that AZT can reduce HIV transmission from an infected woman to her infant by approximately two-thirds. The children in PACTG 076 were exposed to AZT or a placebo in utero and during labor and delivery, and also as newborns for six weeks.

The randomized design of PACTG 076 and subsequent follow-up in this study makes it easier to clearly evaluate AZT's potential toxicity, the investigators note. The health of children who received AZT (122 children) can be compared with that of a similar number of children (112) who received a placebo.

For the current study, the investigators evaluated the children at regular intervals. The main measures of interest included physical growth, cognitive and development milestones, immunologic function, cardiac and ophthalmologic evaluations, the occurrence of malignancies, and mortality.

"The good news is that there are no differences in growth and cognitive development between the children exposed to AZT versus the children who were not," comments lead author Mary Culnane, M.S., C.R.N.P, of NIAID's pediatric medicine branch in the Division of AIDS. "It also is reassuring that none of the children have developed cancers or died."

The JAMA article reports on data collected through February 1997. The median age of the children was 4.2 years (range 3.2 to 5.6 years). They continue to be followed in the PACTG clinics.

The authors conclude that their findings complement the earlier findings of PACTG 076, which found no evidence of AZT toxicity in children up to 18 months of age, and are consistent with the limited other early safety data concerning perinatal exposure to AZT. Future evaluations of these and other children in PACTG 219 will help define the long-term safety of AZT use during the perinatal period. Pediatric HIV specialists also hope to establish a registry to track the health of all children exposed to antiretrovirals, a proposal that is being actively discussed within the medical community.
-end-
NIAID and NICHD are components of the National Institutes of Health (NIH). NIAID conducts and supports research to prevent, diagnose and treat illnesses such as HIV disease and other sexually transmitted diseases, tuberculosis, malaria, asthma and allergies. NICHD supports and conducts basic, clinical and epidemiological research on the reproductive, developmental and behavioral processes that determine and maintain the health of children, adults, families and populations. NIH is an agency of the U.S. Department of Health and Human Services.

Reference:
M Culnane, MG Fowler, SS Lee, G McSherry, M Brady, K O'Donnell, L Mofenson, SL Gortmaker, DE Shapiro, G Scott, E Jimenez, EC Moore, C Diaz, PM Flynn, B Cunningham and J Oleske. Lack of long-term effects among uninfected children exposed to zidovudine. The Journal of the American Medical Association 281(2), 151-57 (1999).



NIH/National Institute of Allergy and Infectious Diseases

Related Cognitive Development Articles from Brightsurf:

DNA repair supports brain cognitive development
Researchers at Osaka University showed that the enzyme PolĪ² functions in genome maintenance by preventing double-stranded breaks in DNA during brain development in mice.

Cognitive performance - Better than our predecessors
We employ our cognitive skills daily to assimilate and process information.

Sugary beverages consumed while breastfeeding affects cognitive development in children
New research shows that a high sugar diet during the breastfeeding period can impact developmental outcomes during infancy.

Diet may help preserve cognitive function
According to a recent analysis of data from two major eye disease studies, adherence to the Mediterranean diet - high in vegetables, whole grains, fish, and olive oil -- correlates with higher cognitive function.

Component of human breast milk enhances cognitive development in babies
CHLA investigators show that early exposure to a carbohydrate found in breast milk, called 2'FL, positively influences neurodevelopment.

The brain may need iron for healthy cognitive development
Iron levels in brain tissue rise during development and are correlated with cognitive abilities, according to research in children and young adults recently published in JNeurosci.

Looking at the way we walk can help predict cognitive decline
The way people walk is an indicator of how much their brains, as well as their bodies, are aging.

Launch of standardised tool to assess cognitive and language development in two year olds
A new paper published in The Lancet Child & Adolescent Health co-authored by a University of Warwick researcher provides standardised scores for The Parent Report of Children's Abilities Revised (PARCA-R) questionnaire.

Examining cognitive, motor development of children exposed prenatally to opioids
Called a systematic review and meta-analysis, this study combined the results of 26 studies to examine the cognitive and motor development of infants and children exposed to opioids prenatally.

Women face more cognitive issues after brain tumor radiation women face more cognitive issues after
Young women who undergo radiation therapy to treat a pediatric brain tumor are more likely to suffer from long-term cognitive impairment than male survivors, according to a study by Georgia State University researchers.

Read More: Cognitive Development News and Cognitive Development Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.